<?xml version="1.0" encoding="UTF-8"?><protocol_summary><protocol><id>15181</id><no>EIK1001-005-FSQ</no><status>Open (affiliates only)</status><title>A Phase 2 Study of EIK1001 in Combination with Pembrolizumab and Chemotherapy in Patients with Stage 4 Non-Small Cell Lung Cancer</title><nct_id>NCT06246110</nct_id><sponsor_type>Industrial</sponsor_type><age_group>Adult</age_group><treatment_type>Treatment</treatment_type><phase>II</phase><disease_site>Lung</disease_site><PI>Chen, Kevin</PI><institution>Medstar Franklin Square Medical Center</institution><oncology_group>Thoracic/CNS/H&amp;N/Thyroid<DOWG_name>Oncology Group</DOWG_name></oncology_group><management_group>MHRI Oncology Baltimore</management_group></protocol><sipVersion>2026.1.0 Build 16</sipVersion><copyright> &lt;a href="https://advarra.com" target="_blank"&gt;&amp;copy; 2026 Advarra, Inc.&lt;/a&gt; </copyright></protocol_summary>